| Outcome Measures: |
Primary: Changes from baseline in HbA1c (%), Changes in HbA1c at 6 months, 12 months and 24 months after initiation of the treatment with exenatide and basal insulin will be calculated and compared., 6, 12 and 24 months|Changes from baseline in weight (kg), Changes in weight at 6 months, 12 months and 24 months after initiation of the treatment with exenatide and basal insulin will be calculated and compared., 6, 12 and 24 months|Changes from baseline in composite outcomes of HbA1c<=7.0% and weight reduction, Changes in composite outcome of HbA1c\<=7.0% and any weight reduction or HbA1c\<=7.0% and weight reduction\>=5% at 6 months, 12 months and 24 months after initiation of the treatment with exenatide and basal insulin will be calculated and compared., 6, 12 and 24 months | Secondary: Health care utilization, Costs of health service contacts after initiation of therapy with exenatide and basal insulin will be calculated and compared using the Mann-Whitney U-test., 12 months
|
